Search - tctmd.com

Displaying 861 - 880 of 985

Sort: Relevancy | Date

Presentation THT 2025

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Presenter: Abduljabar Adi

February 11, 2025

Presentation THT 2025

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Presenter: Anthony Carnicelli

February 11, 2025

Presentation THT 2025

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

Presenter: Jonathan Zawadzki

February 11, 2025

Presentation THT 2025

The Enduring Unmet Clinical Needs Amongst Patients Treated for Heart Failure

Presenter: Jane Wilcox

February 11, 2025

Presentation THT 2025

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Presenter: Marat Fudim

February 11, 2025

Presentation THT 2025

Cardiac Microcurrent Application for the Reversal of Heart Failure

Presenter: Eduardo Rame

February 11, 2025

Presentation THT 2025

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Presenter: Sanjiv Shah

February 11, 2025

Presentation THT 2025

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Presenter: Stefan Anker

February 11, 2025

Presentation THT 2025

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Presenter: Barry Borlaug

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Electrophysiological Characteristics and Clinical Outcomes of Truncal, Fascicular and Left Ventricular Septal Pacing in Patients Receiving Left Bundle Branch Area Pacing

Presenter: Shunmuga Ponnusamy

February 11, 2025

Presentation THT 2025

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

Presenter: Allan Böhm

February 11, 2025

Presentation THT 2025

Salt and HF: Addressing the Controversies of Molecular Mechanisms, Physiology, Clinical Data

Presenter: Jeffrey Testani

February 11, 2025

Presentation THT 2025

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Presenter: Mahir Karakas

February 11, 2025

Presentation THT 2025

Harnessing Real World Data to Test Emerging Technologies

Presenter: Robert Yeh

February 11, 2025

Presentation THT 2025

Time to Escalation: From the Golden Day to the Golden Six Hours

Presenter: Elric Zweck

February 11, 2025

Presentation THT 2025

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Presenter: Shelley Hall

February 11, 2025

Presentation THT 2025

Optimizing Outcomes in Cardiac Arrest and Shock

Presenter: Jacqueline Tamis-Holland

February 11, 2025

Presentation THT 2025

Special Late-Breaking Clinical Science Abstract: Hemodynamic Effects of Intravenous Istaroxime in Patients With SCAI Stage B Cardiogenic Shock: Insights From the SEISMiC Trial

Presenter: Matteo Pagnesi

February 11, 2025

Presentation THT 2025

Only Select Patients Should Have a PA Pressure Sensor

Presenter: Maria Rosa Costanzo

February 11, 2025

Presentation THT 2025

All NYHA III Patients Should Have a PA Pressure Sensor

Presenter: Michael Givertz

February 11, 2025

Advertisement

Impact of Obesity on Clinical Outcomes of Cardiogenic Shock Patients Treated With Advanced Mechanical Circulatory Support

Management of Clinically Stable Patients With Impella 5.5 on a Cardiac Stepdown Unit Is Associated With Low Adverse Event Rates and Lower Hospital Costs

Association of SGLT2 Inhibitors With Clinical Outcomes in Patients With Severe Renal Impairment (Estimated Glomerular Filtration Rate < 30) and Heart Failure With Reduced Ejection Fraction (HFrEF)

The Enduring Unmet Clinical Needs Amongst Patients Treated for Heart Failure

Inflammation and Heart Failure: Pathophysiology and Clinical Implications

Cardiac Microcurrent Application for the Reversal of Heart Failure

Atrial Shunt for Heart Failure With Preserved and Mildly Reduced Ejection Fraction: Five-Year Outcomes in the REDUCE LAP-HF II Trial

Right Ventricular to Pulmonary Artery Coupling and Clinical Outcomes After Interatrial Shunting in Heart Failure

Duration of Heart Failure, Cardiac Dysfunction and Remodeling, and Response to Atrial Shunt Treatment in HFpEF and HFmrEF

Special Late-Breaking Clinical Science Abstract: Electrophysiological Characteristics and Clinical Outcomes of Truncal, Fascicular and Left Ventricular Septal Pacing in Patients Receiving Left Bundle Branch Area Pacing

Strategy to Prevent Cardiogenic SHOCK: Randomised Clinical Trial (STOPSHOCK - RCT)

Salt and HF: Addressing the Controversies of Molecular Mechanisms, Physiology, Clinical Data

Drug Therapy to Improve Shock Outcomes: The Emerging DPP3 Story

Harnessing Real World Data to Test Emerging Technologies

Time to Escalation: From the Golden Day to the Golden Six Hours

Cardiogenic Shock in the Post-DanGer Shock Trial Era

Optimizing Outcomes in Cardiac Arrest and Shock

Special Late-Breaking Clinical Science Abstract: Hemodynamic Effects of Intravenous Istaroxime in Patients With SCAI Stage B Cardiogenic Shock: Insights From the SEISMiC Trial

Only Select Patients Should Have a PA Pressure Sensor

All NYHA III Patients Should Have a PA Pressure Sensor

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content